1.705
前日終値:
$1.565
開ける:
$1.69
24時間の取引高:
32.67M
Relative Volume:
51.01
時価総額:
$39.90M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+28.84%
1か月 パフォーマンス:
+46.16%
6か月 パフォーマンス:
-4.43%
1年 パフォーマンス:
+0.00%
Rein Therapeutics Inc Stock (RNTX) Company Profile
RNTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
RNTX
Rein Therapeutics Inc
|
1.712 | 37.60M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-22 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2017-07-24 | 開始されました | BofA/Merrill | Buy |
| 2017-07-24 | 開始されました | Jefferies | Buy |
| 2017-07-24 | 開始されました | William Blair | Outperform |
Rein Therapeutics Inc (RNTX) 最新ニュース
Rein Therapeutics Receives FDA Clearance to Resume Phase 2 Trial - TradingView
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis - The Manila Times
How Rein Therapeutics Inc. stock reacts to bond yieldsJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Ranking Rein Therapeutics Inc. among high performing stocks via toolsQuarterly Investment Review & Weekly Hot Stock Watchlists - newser.com
Technical signs of recovery in Rein Therapeutics Inc.July 2025 Catalysts & Community Consensus Stock Picks - newser.com
Multi asset correlation models including Rein Therapeutics Inc.Weekly Trend Summary & Daily Growth Stock Tips - newser.com
Why Rein Therapeutics Inc. stock attracts high net worth investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
News impact scoring models applied to Rein Therapeutics Inc.Weekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
Price momentum metrics for Rein Therapeutics Inc. explainedEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com
Will Rein Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
Using economic indicators to assess Rein Therapeutics Inc. potential2025 AllTime Highs & Detailed Earnings Play Strategies - newser.com
Why retail investors pile into Rein Therapeutics Inc. stock2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com
Rein Therapeutics Inc. stock retracement – recovery analysis2025 Geopolitical Influence & AI Driven Price Predictions - newser.com
Rein Therapeutics Inc. Stock (RNTX) Opinions on Institutional Investments and Funding Deals - Quiver Quantitative
Is Rein Therapeutics Inc. stock a defensive play in 20252025 Market WrapUp & AI Based Trade Execution Alerts - fcp.pa.gov.br
How rising interest rates impact Rein Therapeutics Inc. stock2025 Growth vs Value & AI Driven Stock Reports - fcp.pa.gov.br
VIX Spike: How rising interest rates impact Rein Therapeutics Inc. stockBond Market & Real-Time Volume Analysis Alerts - fcp.pa.gov.br
Applying sector rotation models to Rein Therapeutics Inc.2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
Rein Therapeutics Inc (RNTX) 財務データ
Rein Therapeutics Inc (RNTX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Rein Therapeutics Inc (RNTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 10% Owner |
Oct 27 '25 |
Buy |
1.37 |
97,482 |
133,544 |
822,258 |
| Voss Capital, LP | 10% Owner |
Oct 24 '25 |
Buy |
1.39 |
30,176 |
41,957 |
729,616 |
| WINDSOR JAMES BRIAN | President and CEO |
Dec 05 '24 |
Buy |
2.24 |
400 |
898 |
239 |
大文字化:
|
ボリューム (24 時間):